tetano
Editor, Senior Moderator
JACC Case Rep
. 2022 Mar 29.
doi: 10.1016/j.jaccas.2022.03.013. Online ahead of print.
Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
Saurabh Rajpal[SUP] 1 [/SUP], Rami Kahwash[SUP] 1 [/SUP], Matthew S Tong[SUP] 1 [/SUP], Kelly Paschke[SUP] 1 [/SUP], Anjali A Satoskar[SUP] 2 [/SUP], Beth Foreman[SUP] 1 [/SUP], Larry A Allen[SUP] 3 [/SUP], Nicole M Bhave[SUP] 4 [/SUP], Ty J Gluckman[SUP] 5 [/SUP], Valentin Fuster[SUP] 6 [/SUP]
Affiliations
Abstract
A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter defibrillator and antiarrhythmic drug therapy.
Keywords: CMR, Cardiac magnetic resonance imaging; COVID-19, Coronavirus disease of 2019; CRRT, Continuous renal replacement therapy; CT Scan, Computed tomography scan; EMB, Endomyocardial biopsy; LVEF, Left ventricular ejection fraction; SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2; SPO2, oxygen saturation by pulse oximetry; VA ECMO, Veno-arterial extracorporeal membrane oxygenation; VT, Ventricular tachycardia.
. 2022 Mar 29.
doi: 10.1016/j.jaccas.2022.03.013. Online ahead of print.
Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
Saurabh Rajpal[SUP] 1 [/SUP], Rami Kahwash[SUP] 1 [/SUP], Matthew S Tong[SUP] 1 [/SUP], Kelly Paschke[SUP] 1 [/SUP], Anjali A Satoskar[SUP] 2 [/SUP], Beth Foreman[SUP] 1 [/SUP], Larry A Allen[SUP] 3 [/SUP], Nicole M Bhave[SUP] 4 [/SUP], Ty J Gluckman[SUP] 5 [/SUP], Valentin Fuster[SUP] 6 [/SUP]
Affiliations
- PMID: 35373150
- PMCID: PMC8961314
- DOI: 10.1016/j.jaccas.2022.03.013
Abstract
A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter defibrillator and antiarrhythmic drug therapy.
Keywords: CMR, Cardiac magnetic resonance imaging; COVID-19, Coronavirus disease of 2019; CRRT, Continuous renal replacement therapy; CT Scan, Computed tomography scan; EMB, Endomyocardial biopsy; LVEF, Left ventricular ejection fraction; SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2; SPO2, oxygen saturation by pulse oximetry; VA ECMO, Veno-arterial extracorporeal membrane oxygenation; VT, Ventricular tachycardia.